[1] 朱星宇, 赵根华, 高倩倩, 等. 对照提取物法测定补骨脂饮片中7种成分含量[J]. 中国实验方剂学杂志, 2017, 23(15):85-91.
[2] 颜冬梅, 高秀梅. 补骨脂化学成分研究进展[J]. 辽宁中医药大学学报, 2012, 14(9):96-99.
[3] 樊玲, 秋新松, 高阳, 等. HPLC法同时测定中药补骨脂中10种成分的含量[J]. 齐齐哈尔医学院学报, 2018, 39(16):1928-1931. doi:  10.3969/j.issn.1002-1256.2018.16.031
[4]

WANG Y F, WU B, YANG J, et al. A rapid method for the analysis of ten compounds in Psoralea corylifolia L. by UPLC[J]. Chromatographia,2009,70(1-2):199-204. doi:  10.1365/s10337-009-1118-8
[5] 邱蓉丽, 李璘, 乐巍. 补骨脂的化学成分与药理作用研究进展[J]. 中药材, 2010, 33(10):1656-1659.
[6] 吴疆, 魏巍, 袁永兵. 补骨脂的化学成分和药理作用研究进展[J]. 药物评价研究, 2011, 34(3):217-219.
[7] 王安红, 周昆, 柴丽娟. 补骨脂素对HepG2细胞BSEP、NTCP的影响[J]. 时珍国医国药, 2015, 26(7):1563-1565.
[8]

PAULI-MAGNUS C, MEIER P J. Hepatobiliary transporters and drug-induced cholestasis[J]. Hepatology,2006,44(4):778-787. doi:  10.1002/hep.21359
[9] 张新颖, 毛景东, 杨晓燕, 等. AMPK/mTOR信号通路的研究进展[J]. 微生物学杂志, 2019, 39(3):109-116. doi:  10.3969/j.issn.1005-7021.2019.03.015
[10] 张玥, 毕亚男, 袁晓美, 等. 基于靶器官的补骨脂肝毒性成分探讨[J]. 时珍国医国药, 2017, 28(8):1844-1847.
[11] 周昆, 毕亚男, 史红. 异补骨脂素抑制MRP2、MRP3所致的HepG2细胞内胆汁酸蓄积和毒性[J]. 中国药理学通报, 2015, 31(8):1112-1116. doi:  10.3969/j.issn.1001-1978.2015.08.017
[12] 李艾芳, 沈国林, 焦士勇, 等. 细胞色素P450介导的补骨脂酚代谢减毒[J]. 北京大学学报(医学版), 2012, 44(3):431-436.
[13]

YANG Y, YING G X, WU F T, et al. sTim-3 alleviates liver injury via regulation of the immunity microenvironment and autophagy[J]. Cell Death Discov,2020,6:62.
[14]

YEW W W, CHANG K C, CHAN D P. Oxidative stress and first-line antituberculosis drug-induced hepatotoxicity[J]. Antimicrob Agents Chemother,2018,62(8):e02637-17.
[15]

WILDE B, KATSOUNAS A. Immune dysfunction and albumin-related immunity in liver cirrhosis[J]. Mediators Inflamm,2019,2019:7537649.
[16]

ARAKAWA K, IKEYAMA Y, SATO T, et al. Functional modulation of liver mitochondria in lipopolysaccharide/drug co-treated rat liver injury model[J]. J Toxicol Sci,2019,44(12):833-843. doi:  10.2131/jts.44.833
[17]

ZHU H Y, CHAI Y C, DONG D H, et al. AICAR-induced AMPK activation inhibits the noncanonical NF-κB pathway to attenuate liver injury and fibrosis in BDL rats[J]. Can J Gastroenterol Hepatol,2018,2018:6181432.
[18]

XING W, YANG L, PENG Y, et al. Ginsenoside Rg3 attenuates Sepsis-induced injury and mitochondrial dysfunction in liver via AMPK-mediated autophagy flux[J]. Biosci Rep,2017,37(4):BSR20170934. doi:  10.1042/BSR20170934
[19]

DONG S, CHEN Q L, SONG Y N, et al. Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis[J]. J Toxicol Sci,2016,41(4):561-572. doi:  10.2131/jts.41.561
[20]

XU M J, CAI Y, WANG H, et al. Fat-specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans[J]. Gastroenterology,2015,149(4):1030-1041.e6. doi:  10.1053/j.gastro.2015.06.009
[21]

LAITAKARI A, OLLONEN T, KIETZMANN T, et al. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease[J]. Redox Biol,2019,22:101145. doi:  10.1016/j.redox.2019.101145
[22]

WANG Y X, DU Y, LIU X F, et al. A hepatoprotection study of Radix Bupleuri on acetaminophen-induced liver injury based on CYP450 inhibition[J]. Chin J Nat Med,2019,17(7):517-524.